News Room

Follow:
52478 Articles

Bristol-Myers Squibb: Growth Portfolio Surpasses Legacy, Driving Oncology And Immunology Leadership (NYSE:BMY)

This article was written byFollowDear Reader,I am a Senior Derivatives Expert with over 10 years of experience in the field

Two Retirement Bargains With Upside Potential

This article was written byFollowRoberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape

G-III: More Challenges Ahead This Year, And They Should Offer Better Opportunities (GIII)

This article was written byFollowLong-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.